nodes	percent_of_prediction	percent_of_DWPC	metapath
Alimemazine—CYP3A4—prostate cancer	0.329	1	CbGaD
Alimemazine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0995	0.207	CbGbCtD
Alimemazine—CYP3A4—Bicalutamide—prostate cancer	0.0523	0.109	CbGbCtD
Alimemazine—CYP3A4—Estramustine—prostate cancer	0.0486	0.101	CbGbCtD
Alimemazine—CYP3A4—Abiraterone—prostate cancer	0.0433	0.09	CbGbCtD
Alimemazine—CYP3A4—Flutamide—prostate cancer	0.0433	0.09	CbGbCtD
Alimemazine—CYP3A4—Cabazitaxel—prostate cancer	0.032	0.0666	CbGbCtD
Alimemazine—CYP3A4—Estrone—prostate cancer	0.0313	0.0651	CbGbCtD
Alimemazine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0279	0.058	CbGbCtD
Alimemazine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0205	0.0426	CbGbCtD
Alimemazine—CYP3A4—Mitoxantrone—prostate cancer	0.0186	0.0387	CbGbCtD
Alimemazine—CYP3A4—Estradiol—prostate cancer	0.018	0.0374	CbGbCtD
Alimemazine—CYP3A4—Prednisone—prostate cancer	0.0155	0.0321	CbGbCtD
Alimemazine—Electrocardiogram U wave present—Degarelix—prostate cancer	0.0136	0.0903	CcSEcCtD
Alimemazine—Electrocardiogram U-wave abnormality—Degarelix—prostate cancer	0.0136	0.0903	CcSEcCtD
Alimemazine—CYP3A4—Etoposide—prostate cancer	0.0117	0.0244	CbGbCtD
Alimemazine—CYP3A4—Docetaxel—prostate cancer	0.0107	0.0223	CbGbCtD
Alimemazine—CYP3A4—Doxorubicin—prostate cancer	0.00801	0.0166	CbGbCtD
Alimemazine—Galactorrhoea—Estrone—prostate cancer	0.00316	0.021	CcSEcCtD
Alimemazine—Galactorrhoea—Flutamide—prostate cancer	0.00292	0.0195	CcSEcCtD
Alimemazine—Galactorrhoea—Estradiol valerate/Dienogest—prostate cancer	0.00276	0.0184	CcSEcCtD
Alimemazine—Jaundice cholestatic—Estrone—prostate cancer	0.00233	0.0155	CcSEcCtD
Alimemazine—Jaundice cholestatic—Flutamide—prostate cancer	0.00216	0.0144	CcSEcCtD
Alimemazine—Jaundice cholestatic—Estradiol valerate/Dienogest—prostate cancer	0.00203	0.0136	CcSEcCtD
Alimemazine—Gynaecomastia—Estramustine—prostate cancer	0.00192	0.0128	CcSEcCtD
Alimemazine—Galactorrhoea—Ethinyl Estradiol—prostate cancer	0.00179	0.0119	CcSEcCtD
Alimemazine—Gynaecomastia—Nilutamide—prostate cancer	0.0017	0.0113	CcSEcCtD
Alimemazine—Atrial arrhythmia—Capecitabine—prostate cancer	0.0017	0.0113	CcSEcCtD
Alimemazine—Gynaecomastia—Flutamide—prostate cancer	0.00169	0.0113	CcSEcCtD
Alimemazine—Gynaecomastia—Degarelix—prostate cancer	0.00152	0.0101	CcSEcCtD
Alimemazine—Galactorrhoea—Goserelin—prostate cancer	0.00147	0.00981	CcSEcCtD
Alimemazine—Galactorrhoea—Conjugated Estrogens—prostate cancer	0.00146	0.00972	CcSEcCtD
Alimemazine—Electrocardiogram ST segment depression—Epirubicin—prostate cancer	0.00145	0.00966	CcSEcCtD
Alimemazine—Hypokalaemia—Abiraterone—prostate cancer	0.00138	0.00917	CcSEcCtD
Alimemazine—Electrocardiogram ST segment depression—Doxorubicin—prostate cancer	0.00134	0.00893	CcSEcCtD
Alimemazine—Amenorrhoea—Ethinyl Estradiol—prostate cancer	0.00132	0.0088	CcSEcCtD
Alimemazine—Erectile dysfunction—Estramustine—prostate cancer	0.00124	0.00825	CcSEcCtD
Alimemazine—Gynaecomastia—Bicalutamide—prostate cancer	0.00123	0.00819	CcSEcCtD
Alimemazine—Arrhythmia supraventricular—Capecitabine—prostate cancer	0.00122	0.00812	CcSEcCtD
Alimemazine—Galactorrhoea—Estradiol—prostate cancer	0.00117	0.00778	CcSEcCtD
Alimemazine—Erectile dysfunction—Nilutamide—prostate cancer	0.0011	0.00732	CcSEcCtD
Alimemazine—Erectile dysfunction—Flutamide—prostate cancer	0.00109	0.00729	CcSEcCtD
Alimemazine—Amenorrhoea—Goserelin—prostate cancer	0.00109	0.00724	CcSEcCtD
Alimemazine—Photosensitivity reaction—Flutamide—prostate cancer	0.00108	0.00723	CcSEcCtD
Alimemazine—Jaundice cholestatic—Conjugated Estrogens—prostate cancer	0.00108	0.00718	CcSEcCtD
Alimemazine—Amenorrhoea—Conjugated Estrogens—prostate cancer	0.00108	0.00718	CcSEcCtD
Alimemazine—Orthostatic hypotension—Cabazitaxel—prostate cancer	0.00106	0.00707	CcSEcCtD
Alimemazine—Hypokalaemia—Cabazitaxel—prostate cancer	0.00106	0.00705	CcSEcCtD
Alimemazine—Jaundice—Flutamide—prostate cancer	0.00103	0.00688	CcSEcCtD
Alimemazine—Altered state of consciousness—Capecitabine—prostate cancer	0.00102	0.00682	CcSEcCtD
Alimemazine—Erectile dysfunction—Degarelix—prostate cancer	0.000982	0.00654	CcSEcCtD
Alimemazine—Cardiac disorder—Abiraterone—prostate cancer	0.000971	0.00647	CcSEcCtD
Alimemazine—Arrhythmia—Abiraterone—prostate cancer	0.000934	0.00622	CcSEcCtD
Alimemazine—Amenorrhoea—Estradiol—prostate cancer	0.000862	0.00574	CcSEcCtD
Alimemazine—Jaundice cholestatic—Estradiol—prostate cancer	0.000862	0.00574	CcSEcCtD
Alimemazine—Gynaecomastia—Goserelin—prostate cancer	0.000855	0.0057	CcSEcCtD
Alimemazine—Eosinophilia—Bicalutamide—prostate cancer	0.000853	0.00568	CcSEcCtD
Alimemazine—Cardiac disorder—Estradiol valerate/Dienogest—prostate cancer	0.000833	0.00555	CcSEcCtD
Alimemazine—Dyskinesia—Estradiol—prostate cancer	0.000806	0.00537	CcSEcCtD
Alimemazine—Amenorrhoea—Mitoxantrone—prostate cancer	0.000803	0.00535	CcSEcCtD
Alimemazine—Erectile dysfunction—Bicalutamide—prostate cancer	0.000794	0.00529	CcSEcCtD
Alimemazine—Cardiac disorder—Degarelix—prostate cancer	0.000792	0.00528	CcSEcCtD
Alimemazine—Arrhythmia—Degarelix—prostate cancer	0.000762	0.00508	CcSEcCtD
Alimemazine—Jaundice—Bicalutamide—prostate cancer	0.000749	0.00499	CcSEcCtD
Alimemazine—Cardiac disorder—Cabazitaxel—prostate cancer	0.000746	0.00497	CcSEcCtD
Alimemazine—Infection—Abiraterone—prostate cancer	0.000738	0.00492	CcSEcCtD
Alimemazine—Arrhythmia—Cabazitaxel—prostate cancer	0.000718	0.00479	CcSEcCtD
Alimemazine—Dry mouth—Nilutamide—prostate cancer	0.000692	0.00461	CcSEcCtD
Alimemazine—Insomnia—Estramustine—prostate cancer	0.000692	0.00461	CcSEcCtD
Alimemazine—Gynaecomastia—Estradiol—prostate cancer	0.000678	0.00451	CcSEcCtD
Alimemazine—Insomnia—Abiraterone—prostate cancer	0.000672	0.00448	CcSEcCtD
Alimemazine—Cardiac disorder—Bicalutamide—prostate cancer	0.00064	0.00426	CcSEcCtD
Alimemazine—Nervous system disorder—Estradiol valerate/Dienogest—prostate cancer	0.000625	0.00417	CcSEcCtD
Alimemazine—Hypokalaemia—Conjugated Estrogens—prostate cancer	0.000625	0.00417	CcSEcCtD
Alimemazine—Dry mouth—Degarelix—prostate cancer	0.000619	0.00412	CcSEcCtD
Alimemazine—Arrhythmia—Bicalutamide—prostate cancer	0.000616	0.0041	CcSEcCtD
Alimemazine—Insomnia—Nilutamide—prostate cancer	0.000614	0.00409	CcSEcCtD
Alimemazine—Insomnia—Flutamide—prostate cancer	0.000611	0.00407	CcSEcCtD
Alimemazine—Nasal congestion—Estradiol—prostate cancer	0.000604	0.00402	CcSEcCtD
Alimemazine—Nervous system disorder—Degarelix—prostate cancer	0.000595	0.00396	CcSEcCtD
Alimemazine—Body temperature increased—Abiraterone—prostate cancer	0.000587	0.00391	CcSEcCtD
Alimemazine—Dry mouth—Cabazitaxel—prostate cancer	0.000583	0.00388	CcSEcCtD
Alimemazine—Infection—Cabazitaxel—prostate cancer	0.000567	0.00378	CcSEcCtD
Alimemazine—Hypotension—Degarelix—prostate cancer	0.000567	0.00377	CcSEcCtD
Alimemazine—Nervous system disorder—Cabazitaxel—prostate cancer	0.00056	0.00373	CcSEcCtD
Alimemazine—Amenorrhoea—Docetaxel—prostate cancer	0.000555	0.0037	CcSEcCtD
Alimemazine—Erectile dysfunction—Goserelin—prostate cancer	0.000552	0.00368	CcSEcCtD
Alimemazine—Insomnia—Degarelix—prostate cancer	0.000548	0.00365	CcSEcCtD
Alimemazine—Photosensitivity reaction—Goserelin—prostate cancer	0.000547	0.00365	CcSEcCtD
Alimemazine—Body temperature increased—Nilutamide—prostate cancer	0.000537	0.00357	CcSEcCtD
Alimemazine—Hypotension—Cabazitaxel—prostate cancer	0.000534	0.00356	CcSEcCtD
Alimemazine—Jaundice—Goserelin—prostate cancer	0.000521	0.00347	CcSEcCtD
Alimemazine—Dry mouth—Bicalutamide—prostate cancer	0.0005	0.00333	CcSEcCtD
Alimemazine—Infection—Bicalutamide—prostate cancer	0.000487	0.00324	CcSEcCtD
Alimemazine—Rash—Estramustine—prostate cancer	0.000482	0.00321	CcSEcCtD
Alimemazine—Dermatitis—Estramustine—prostate cancer	0.000482	0.00321	CcSEcCtD
Alimemazine—Nervous system disorder—Bicalutamide—prostate cancer	0.000481	0.0032	CcSEcCtD
Alimemazine—Body temperature increased—Degarelix—prostate cancer	0.000479	0.00319	CcSEcCtD
Alimemazine—Amenorrhoea—Prednisone—prostate cancer	0.000479	0.00319	CcSEcCtD
Alimemazine—Rash—Abiraterone—prostate cancer	0.000468	0.00312	CcSEcCtD
Alimemazine—Dermatitis—Abiraterone—prostate cancer	0.000468	0.00312	CcSEcCtD
Alimemazine—Hypokalaemia—Mitoxantrone—prostate cancer	0.000466	0.00311	CcSEcCtD
Alimemazine—Rash—Estrone—prostate cancer	0.000461	0.00307	CcSEcCtD
Alimemazine—Dermatitis—Estrone—prostate cancer	0.00046	0.00307	CcSEcCtD
Alimemazine—Body temperature increased—Cabazitaxel—prostate cancer	0.000452	0.00301	CcSEcCtD
Alimemazine—Dimetacrine—ACHE—prostate cancer	0.000451	0.0729	CrCbGaD
Alimemazine—Cardiac disorder—Goserelin—prostate cancer	0.000445	0.00297	CcSEcCtD
Alimemazine—Insomnia—Bicalutamide—prostate cancer	0.000443	0.00295	CcSEcCtD
Alimemazine—Cardiac disorder—Conjugated Estrogens—prostate cancer	0.000441	0.00294	CcSEcCtD
Alimemazine—Carbamazepine—RALBP1—prostate cancer	0.000435	0.0703	CrCbGaD
Alimemazine—Photosensitivity reaction—Estradiol—prostate cancer	0.000434	0.00289	CcSEcCtD
Alimemazine—Arrhythmia—Goserelin—prostate cancer	0.000429	0.00286	CcSEcCtD
Alimemazine—Rash—Nilutamide—prostate cancer	0.000428	0.00285	CcSEcCtD
Alimemazine—Dermatitis—Nilutamide—prostate cancer	0.000428	0.00285	CcSEcCtD
Alimemazine—Rash—Flutamide—prostate cancer	0.000426	0.00284	CcSEcCtD
Alimemazine—Dermatitis—Flutamide—prostate cancer	0.000426	0.00284	CcSEcCtD
Alimemazine—Arrhythmia—Conjugated Estrogens—prostate cancer	0.000425	0.00283	CcSEcCtD
Alimemazine—Jaundice—Estradiol—prostate cancer	0.000413	0.00275	CcSEcCtD
Alimemazine—Infection—Ethinyl Estradiol—prostate cancer	0.000411	0.00274	CcSEcCtD
Alimemazine—Erectile dysfunction—Mitoxantrone—prostate cancer	0.000408	0.00272	CcSEcCtD
Alimemazine—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000406	0.00271	CcSEcCtD
Alimemazine—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000402	0.00268	CcSEcCtD
Alimemazine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000402	0.00268	CcSEcCtD
Alimemazine—Photosensitivity—Capecitabine—prostate cancer	0.00039	0.0026	CcSEcCtD
Alimemazine—Body temperature increased—Bicalutamide—prostate cancer	0.000387	0.00258	CcSEcCtD
Alimemazine—Jaundice—Mitoxantrone—prostate cancer	0.000385	0.00256	CcSEcCtD
Alimemazine—Rash—Degarelix—prostate cancer	0.000382	0.00255	CcSEcCtD
Alimemazine—Dermatitis—Degarelix—prostate cancer	0.000382	0.00254	CcSEcCtD
Alimemazine—Amenorrhoea—Epirubicin—prostate cancer	0.000374	0.00249	CcSEcCtD
Alimemazine—Jaundice cholestatic—Epirubicin—prostate cancer	0.000374	0.00249	CcSEcCtD
Alimemazine—Agranulocytosis—Mitoxantrone—prostate cancer	0.000368	0.00245	CcSEcCtD
Alimemazine—Convulsion—Goserelin—prostate cancer	0.000362	0.00241	CcSEcCtD
Alimemazine—Convulsion—Conjugated Estrogens—prostate cancer	0.000358	0.00239	CcSEcCtD
Alimemazine—Cardiac disorder—Estradiol—prostate cancer	0.000353	0.00235	CcSEcCtD
Alimemazine—Dyskinesia—Epirubicin—prostate cancer	0.00035	0.00233	CcSEcCtD
Alimemazine—Dry mouth—Goserelin—prostate cancer	0.000348	0.00232	CcSEcCtD
Alimemazine—Jaundice cholestatic—Doxorubicin—prostate cancer	0.000347	0.00231	CcSEcCtD
Alimemazine—Amenorrhoea—Doxorubicin—prostate cancer	0.000347	0.00231	CcSEcCtD
Alimemazine—Atrioventricular block—Epirubicin—prostate cancer	0.000339	0.00226	CcSEcCtD
Alimemazine—Infection—Goserelin—prostate cancer	0.000339	0.00226	CcSEcCtD
Alimemazine—Infection—Conjugated Estrogens—prostate cancer	0.000335	0.00223	CcSEcCtD
Alimemazine—Nervous system disorder—Goserelin—prostate cancer	0.000334	0.00223	CcSEcCtD
Alimemazine—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000331	0.00221	CcSEcCtD
Alimemazine—Ventricular tachycardia—Epirubicin—prostate cancer	0.000329	0.00219	CcSEcCtD
Alimemazine—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000327	0.00218	CcSEcCtD
Alimemazine—Dyskinesia—Doxorubicin—prostate cancer	0.000324	0.00216	CcSEcCtD
Alimemazine—Orthostatic hypotension—Docetaxel—prostate cancer	0.000323	0.00215	CcSEcCtD
Alimemazine—Jaundice—Etoposide—prostate cancer	0.00032	0.00213	CcSEcCtD
Alimemazine—Hypotension—Goserelin—prostate cancer	0.000319	0.00212	CcSEcCtD
Alimemazine—Arrhythmia—Mitoxantrone—prostate cancer	0.000317	0.00211	CcSEcCtD
Alimemazine—Hypotension—Conjugated Estrogens—prostate cancer	0.000315	0.0021	CcSEcCtD
Alimemazine—Atrioventricular block—Doxorubicin—prostate cancer	0.000314	0.00209	CcSEcCtD
Alimemazine—Orthostatic hypotension—Capecitabine—prostate cancer	0.000313	0.00209	CcSEcCtD
Alimemazine—Hypokalaemia—Capecitabine—prostate cancer	0.000312	0.00208	CcSEcCtD
Alimemazine—Tremor—Estradiol—prostate cancer	0.00031	0.00207	CcSEcCtD
Alimemazine—Rash—Bicalutamide—prostate cancer	0.000309	0.00206	CcSEcCtD
Alimemazine—Dermatitis—Bicalutamide—prostate cancer	0.000309	0.00206	CcSEcCtD
Alimemazine—Insomnia—Goserelin—prostate cancer	0.000308	0.00205	CcSEcCtD
Alimemazine—Agranulocytosis—Etoposide—prostate cancer	0.000306	0.00204	CcSEcCtD
Alimemazine—Insomnia—Conjugated Estrogens—prostate cancer	0.000305	0.00203	CcSEcCtD
Alimemazine—Ventricular tachycardia—Doxorubicin—prostate cancer	0.000304	0.00203	CcSEcCtD
Alimemazine—Agitation—Estradiol—prostate cancer	0.000304	0.00203	CcSEcCtD
Alimemazine—Perphenazine—AOX1—prostate cancer	0.00029	0.0468	CrCbGaD
Alimemazine—Hypokalaemia—Prednisone—prostate cancer	0.000278	0.00185	CcSEcCtD
Alimemazine—Dry mouth—Estradiol—prostate cancer	0.000276	0.00184	CcSEcCtD
Alimemazine—Cardiac disorder—Etoposide—prostate cancer	0.000274	0.00182	CcSEcCtD
Alimemazine—Photosensitivity—Epirubicin—prostate cancer	0.000272	0.00181	CcSEcCtD
Alimemazine—Photosensitivity reaction—Capecitabine—prostate cancer	0.00027	0.0018	CcSEcCtD
Alimemazine—Body temperature increased—Goserelin—prostate cancer	0.000269	0.0018	CcSEcCtD
Alimemazine—Infection—Estradiol—prostate cancer	0.000268	0.00179	CcSEcCtD
Alimemazine—Convulsion—Mitoxantrone—prostate cancer	0.000267	0.00178	CcSEcCtD
Alimemazine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000267	0.00178	CcSEcCtD
Alimemazine—Jaundice—Docetaxel—prostate cancer	0.000266	0.00177	CcSEcCtD
Alimemazine—Nervous system disorder—Estradiol—prostate cancer	0.000265	0.00177	CcSEcCtD
Alimemazine—Rash—Ethinyl Estradiol—prostate cancer	0.000261	0.00174	CcSEcCtD
Alimemazine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000261	0.00174	CcSEcCtD
Alimemazine—Jaundice—Capecitabine—prostate cancer	0.000258	0.00172	CcSEcCtD
Alimemazine—Agranulocytosis—Docetaxel—prostate cancer	0.000255	0.0017	CcSEcCtD
Alimemazine—Photosensitivity—Doxorubicin—prostate cancer	0.000252	0.00168	CcSEcCtD
Alimemazine—Infection—Mitoxantrone—prostate cancer	0.00025	0.00167	CcSEcCtD
Alimemazine—Agranulocytosis—Capecitabine—prostate cancer	0.000247	0.00164	CcSEcCtD
Alimemazine—Insomnia—Estradiol—prostate cancer	0.000244	0.00163	CcSEcCtD
Alimemazine—Erectile dysfunction—Prednisone—prostate cancer	0.000243	0.00162	CcSEcCtD
Alimemazine—Hypotension—Mitoxantrone—prostate cancer	0.000235	0.00157	CcSEcCtD
Alimemazine—Cardiac disorder—Docetaxel—prostate cancer	0.000227	0.00151	CcSEcCtD
Alimemazine—Convulsion—Etoposide—prostate cancer	0.000222	0.00148	CcSEcCtD
Alimemazine—Cardiac disorder—Capecitabine—prostate cancer	0.00022	0.00147	CcSEcCtD
Alimemazine—Arrhythmia—Docetaxel—prostate cancer	0.000219	0.00146	CcSEcCtD
Alimemazine—Orthostatic hypotension—Epirubicin—prostate cancer	0.000218	0.00145	CcSEcCtD
Alimemazine—Hypokalaemia—Epirubicin—prostate cancer	0.000217	0.00145	CcSEcCtD
Alimemazine—Rash—Goserelin—prostate cancer	0.000215	0.00143	CcSEcCtD
Alimemazine—Dermatitis—Goserelin—prostate cancer	0.000215	0.00143	CcSEcCtD
Alimemazine—Body temperature increased—Estradiol—prostate cancer	0.000214	0.00142	CcSEcCtD
Alimemazine—Rash—Conjugated Estrogens—prostate cancer	0.000213	0.00142	CcSEcCtD
Alimemazine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000213	0.00142	CcSEcCtD
Alimemazine—Arrhythmia—Capecitabine—prostate cancer	0.000212	0.00141	CcSEcCtD
Alimemazine—Infection—Etoposide—prostate cancer	0.000208	0.00139	CcSEcCtD
Alimemazine—Eosinophilia—Epirubicin—prostate cancer	0.000204	0.00136	CcSEcCtD
Alimemazine—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000202	0.00134	CcSEcCtD
Alimemazine—Hypokalaemia—Doxorubicin—prostate cancer	0.000201	0.00134	CcSEcCtD
Alimemazine—Body temperature increased—Mitoxantrone—prostate cancer	0.000199	0.00133	CcSEcCtD
Alimemazine—Hypotension—Etoposide—prostate cancer	0.000196	0.0013	CcSEcCtD
Alimemazine—Tremor—Capecitabine—prostate cancer	0.000193	0.00129	CcSEcCtD
Alimemazine—Eosinophilia—Doxorubicin—prostate cancer	0.000189	0.00126	CcSEcCtD
Alimemazine—Arrhythmia—Prednisone—prostate cancer	0.000189	0.00126	CcSEcCtD
Alimemazine—Photosensitivity reaction—Epirubicin—prostate cancer	0.000188	0.00126	CcSEcCtD
Alimemazine—Convulsion—Docetaxel—prostate cancer	0.000185	0.00123	CcSEcCtD
Alimemazine—Jaundice—Epirubicin—prostate cancer	0.000179	0.0012	CcSEcCtD
Alimemazine—Dry mouth—Docetaxel—prostate cancer	0.000178	0.00118	CcSEcCtD
Alimemazine—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000174	0.00116	CcSEcCtD
Alimemazine—Infection—Docetaxel—prostate cancer	0.000173	0.00115	CcSEcCtD
Alimemazine—Oxcarbazepine—CYP3A5—prostate cancer	0.000172	0.0278	CrCbGaD
Alimemazine—Dry mouth—Capecitabine—prostate cancer	0.000172	0.00115	CcSEcCtD
Alimemazine—Agranulocytosis—Epirubicin—prostate cancer	0.000172	0.00114	CcSEcCtD
Alimemazine—Nervous system disorder—Docetaxel—prostate cancer	0.000171	0.00114	CcSEcCtD
Alimemazine—Rash—Estradiol—prostate cancer	0.00017	0.00114	CcSEcCtD
Alimemazine—Dermatitis—Estradiol—prostate cancer	0.00017	0.00113	CcSEcCtD
Alimemazine—Agitation—Prednisone—prostate cancer	0.000169	0.00113	CcSEcCtD
Alimemazine—Infection—Capecitabine—prostate cancer	0.000167	0.00112	CcSEcCtD
Alimemazine—Jaundice—Doxorubicin—prostate cancer	0.000166	0.00111	CcSEcCtD
Alimemazine—Body temperature increased—Etoposide—prostate cancer	0.000166	0.0011	CcSEcCtD
Alimemazine—Nervous system disorder—Capecitabine—prostate cancer	0.000165	0.0011	CcSEcCtD
Alimemazine—Hypotension—Docetaxel—prostate cancer	0.000163	0.00108	CcSEcCtD
Alimemazine—Acepromazine—SLC22A1—prostate cancer	0.000161	0.026	CrCbGaD
Alimemazine—Convulsion—Prednisone—prostate cancer	0.000159	0.00106	CcSEcCtD
Alimemazine—Agranulocytosis—Doxorubicin—prostate cancer	0.000159	0.00106	CcSEcCtD
Alimemazine—Rash—Mitoxantrone—prostate cancer	0.000159	0.00106	CcSEcCtD
Alimemazine—Dermatitis—Mitoxantrone—prostate cancer	0.000159	0.00106	CcSEcCtD
Alimemazine—Diltiazem—CYP3A5—prostate cancer	0.000158	0.0255	CrCbGaD
Alimemazine—Hypotension—Capecitabine—prostate cancer	0.000157	0.00105	CcSEcCtD
Alimemazine—Insomnia—Docetaxel—prostate cancer	0.000157	0.00105	CcSEcCtD
Alimemazine—Thioproperazine—SLC22A1—prostate cancer	0.000157	0.0254	CrCbGaD
Alimemazine—Pipotiazine—SLC22A1—prostate cancer	0.000155	0.025	CrCbGaD
Alimemazine—Cardiac disorder—Epirubicin—prostate cancer	0.000153	0.00102	CcSEcCtD
Alimemazine—Insomnia—Capecitabine—prostate cancer	0.000152	0.00102	CcSEcCtD
Alimemazine—Infection—Prednisone—prostate cancer	0.000149	0.000993	CcSEcCtD
Alimemazine—Arrhythmia—Epirubicin—prostate cancer	0.000148	0.000983	CcSEcCtD
Alimemazine—Nervous system disorder—Prednisone—prostate cancer	0.000147	0.000981	CcSEcCtD
Alimemazine—Cardiac disorder—Doxorubicin—prostate cancer	0.000142	0.000945	CcSEcCtD
Alimemazine—Body temperature increased—Docetaxel—prostate cancer	0.000138	0.000917	CcSEcCtD
Alimemazine—Desipramine—SLC22A3—prostate cancer	0.000137	0.0222	CrCbGaD
Alimemazine—Arrhythmia—Doxorubicin—prostate cancer	0.000137	0.00091	CcSEcCtD
Alimemazine—Insomnia—Prednisone—prostate cancer	0.000136	0.000904	CcSEcCtD
Alimemazine—Diphenhydramine—CYP2C18—prostate cancer	0.000135	0.0219	CrCbGaD
Alimemazine—Body temperature increased—Capecitabine—prostate cancer	0.000133	0.000888	CcSEcCtD
Alimemazine—Clomipramine—GSTP1—prostate cancer	0.000132	0.0214	CrCbGaD
Alimemazine—Agitation—Epirubicin—prostate cancer	0.000132	0.000881	CcSEcCtD
Alimemazine—Rash—Etoposide—prostate cancer	0.000132	0.00088	CcSEcCtD
Alimemazine—Dermatitis—Etoposide—prostate cancer	0.000132	0.000879	CcSEcCtD
Alimemazine—Methadone—CYP2C18—prostate cancer	0.000131	0.0211	CrCbGaD
Alimemazine—Perphenazine—CYP2C18—prostate cancer	0.00013	0.0209	CrCbGaD
Alimemazine—Convulsion—Epirubicin—prostate cancer	0.000125	0.00083	CcSEcCtD
Alimemazine—Agitation—Doxorubicin—prostate cancer	0.000122	0.000815	CcSEcCtD
Alimemazine—Desipramine—CYP2C18—prostate cancer	0.000121	0.0195	CrCbGaD
Alimemazine—Dry mouth—Epirubicin—prostate cancer	0.00012	0.000798	CcSEcCtD
Alimemazine—Body temperature increased—Prednisone—prostate cancer	0.000119	0.000791	CcSEcCtD
Alimemazine—Carbamazepine—CYP3A5—prostate cancer	0.000117	0.0189	CrCbGaD
Alimemazine—Oxcarbazepine—CYP2C19—prostate cancer	0.000117	0.0189	CrCbGaD
Alimemazine—Infection—Epirubicin—prostate cancer	0.000117	0.000777	CcSEcCtD
Alimemazine—Imipramine—SLC22A3—prostate cancer	0.000116	0.0188	CrCbGaD
Alimemazine—Convulsion—Doxorubicin—prostate cancer	0.000115	0.000768	CcSEcCtD
Alimemazine—Nervous system disorder—Epirubicin—prostate cancer	0.000115	0.000767	CcSEcCtD
Alimemazine—Dry mouth—Doxorubicin—prostate cancer	0.000111	0.000738	CcSEcCtD
Alimemazine—Diphenhydramine—SLC22A1—prostate cancer	0.000111	0.0179	CrCbGaD
Alimemazine—Rash—Docetaxel—prostate cancer	0.00011	0.000731	CcSEcCtD
Alimemazine—Hypotension—Epirubicin—prostate cancer	0.00011	0.000731	CcSEcCtD
Alimemazine—Dermatitis—Docetaxel—prostate cancer	0.00011	0.00073	CcSEcCtD
Alimemazine—Infection—Doxorubicin—prostate cancer	0.000108	0.000719	CcSEcCtD
Alimemazine—Diltiazem—CYP2C19—prostate cancer	0.000107	0.0173	CrCbGaD
Alimemazine—Nervous system disorder—Doxorubicin—prostate cancer	0.000107	0.00071	CcSEcCtD
Alimemazine—Rash—Capecitabine—prostate cancer	0.000106	0.000708	CcSEcCtD
Alimemazine—Insomnia—Epirubicin—prostate cancer	0.000106	0.000707	CcSEcCtD
Alimemazine—Dermatitis—Capecitabine—prostate cancer	0.000106	0.000707	CcSEcCtD
Alimemazine—Imipramine—CYP2C18—prostate cancer	0.000102	0.0165	CrCbGaD
Alimemazine—Hypotension—Doxorubicin—prostate cancer	0.000102	0.000676	CcSEcCtD
Alimemazine—Desipramine—SLC22A1—prostate cancer	9.85e-05	0.0159	CrCbGaD
Alimemazine—Insomnia—Doxorubicin—prostate cancer	9.82e-05	0.000655	CcSEcCtD
Alimemazine—Rash—Prednisone—prostate cancer	9.46e-05	0.000631	CcSEcCtD
Alimemazine—Dermatitis—Prednisone—prostate cancer	9.46e-05	0.00063	CcSEcCtD
Alimemazine—Body temperature increased—Epirubicin—prostate cancer	9.28e-05	0.000618	CcSEcCtD
Alimemazine—Methadone—CYP3A5—prostate cancer	8.61e-05	0.0139	CrCbGaD
Alimemazine—Body temperature increased—Doxorubicin—prostate cancer	8.59e-05	0.000572	CcSEcCtD
Alimemazine—Pipotiazine—CYP2C19—prostate cancer	8.5e-05	0.0137	CrCbGaD
Alimemazine—Chlorpromazine—SLC22A1—prostate cancer	8.4e-05	0.0136	CrCbGaD
Alimemazine—Imipramine—SLC22A1—prostate cancer	8.35e-05	0.0135	CrCbGaD
Alimemazine—Cyclobenzaprine—CYP3A4—prostate cancer	8.14e-05	0.0132	CrCbGaD
Alimemazine—Carbamazepine—CYP2C19—prostate cancer	7.98e-05	0.0129	CrCbGaD
Alimemazine—Methadone—CYP19A1—prostate cancer	7.94e-05	0.0128	CrCbGaD
Alimemazine—Desipramine—CYP2A6—prostate cancer	7.69e-05	0.0124	CrCbGaD
Alimemazine—Mequitazine—CYP3A4—prostate cancer	7.6e-05	0.0123	CrCbGaD
Alimemazine—Oxcarbazepine—CYP3A4—prostate cancer	7.44e-05	0.012	CrCbGaD
Alimemazine—Rash—Epirubicin—prostate cancer	7.4e-05	0.000493	CcSEcCtD
Alimemazine—Dermatitis—Epirubicin—prostate cancer	7.4e-05	0.000493	CcSEcCtD
Alimemazine—Rash—Doxorubicin—prostate cancer	6.85e-05	0.000456	CcSEcCtD
Alimemazine—Dermatitis—Doxorubicin—prostate cancer	6.84e-05	0.000456	CcSEcCtD
Alimemazine—Diltiazem—CYP3A4—prostate cancer	6.82e-05	0.011	CrCbGaD
Alimemazine—Clomipramine—CYP2C19—prostate cancer	6.72e-05	0.0109	CrCbGaD
Alimemazine—Amitriptyline—CYP3A5—prostate cancer	6.7e-05	0.0108	CrCbGaD
Alimemazine—Thioridazine—CYP2E1—prostate cancer	6.39e-05	0.0103	CrCbGaD
Alimemazine—Thioridazine—CYP2C19—prostate cancer	6.33e-05	0.0102	CrCbGaD
Alimemazine—Desipramine—ADRB2—prostate cancer	6.28e-05	0.0102	CrCbGaD
Alimemazine—Trimipramine—CYP2C19—prostate cancer	6.19e-05	0.01	CrCbGaD
Alimemazine—Methotrimeprazine—CYP2E1—prostate cancer	6.1e-05	0.00987	CrCbGaD
Alimemazine—Diphenhydramine—CYP2C19—prostate cancer	6.07e-05	0.00982	CrCbGaD
Alimemazine—Doxepin—CYP2C19—prostate cancer	5.89e-05	0.00953	CrCbGaD
Alimemazine—Methadone—CYP2C19—prostate cancer	5.86e-05	0.00948	CrCbGaD
Alimemazine—Perphenazine—CYP2C19—prostate cancer	5.81e-05	0.00939	CrCbGaD
Alimemazine—Orphenadrine—CYP2E1—prostate cancer	5.8e-05	0.00938	CrCbGaD
Alimemazine—Dextropropoxyphene—CYP3A4—prostate cancer	5.5e-05	0.00888	CrCbGaD
Alimemazine—Desipramine—CYP2E1—prostate cancer	5.46e-05	0.00883	CrCbGaD
Alimemazine—Desipramine—CYP2C19—prostate cancer	5.41e-05	0.00874	CrCbGaD
Alimemazine—Pipotiazine—CYP3A4—prostate cancer	5.41e-05	0.00874	CrCbGaD
Alimemazine—Promazine—CYP2C19—prostate cancer	5.24e-05	0.00847	CrCbGaD
Alimemazine—Prochlorperazine—CYP3A4—prostate cancer	5.17e-05	0.00835	CrCbGaD
Alimemazine—Carbamazepine—CYP3A4—prostate cancer	5.07e-05	0.0082	CrCbGaD
Alimemazine—Benzphetamine—CYP3A4—prostate cancer	4.82e-05	0.00779	CrCbGaD
Alimemazine—Chlorpromazine—CYP2E1—prostate cancer	4.66e-05	0.00753	CrCbGaD
Alimemazine—Imipramine—CYP2E1—prostate cancer	4.63e-05	0.00749	CrCbGaD
Alimemazine—Amitriptyline—CYP2E1—prostate cancer	4.6e-05	0.00744	CrCbGaD
Alimemazine—Imipramine—CYP2C19—prostate cancer	4.59e-05	0.00741	CrCbGaD
Alimemazine—Amitriptyline—CYP2C19—prostate cancer	4.56e-05	0.00737	CrCbGaD
Alimemazine—Clomipramine—CYP3A4—prostate cancer	4.27e-05	0.00691	CrCbGaD
Alimemazine—Trimipramine—CYP3A4—prostate cancer	3.93e-05	0.00636	CrCbGaD
Alimemazine—Doxepin—CYP3A4—prostate cancer	3.75e-05	0.00606	CrCbGaD
Alimemazine—Methadone—CYP3A4—prostate cancer	3.73e-05	0.00603	CrCbGaD
Alimemazine—Perphenazine—CYP3A4—prostate cancer	3.7e-05	0.00597	CrCbGaD
Alimemazine—Orphenadrine—CYP3A4—prostate cancer	3.65e-05	0.0059	CrCbGaD
Alimemazine—Desipramine—CYP3A4—prostate cancer	3.44e-05	0.00556	CrCbGaD
Alimemazine—Promazine—CYP3A4—prostate cancer	3.33e-05	0.00538	CrCbGaD
Alimemazine—Chlorpromazine—CYP3A4—prostate cancer	2.93e-05	0.00474	CrCbGaD
Alimemazine—Imipramine—CYP3A4—prostate cancer	2.92e-05	0.00471	CrCbGaD
Alimemazine—Amitriptyline—CYP3A4—prostate cancer	2.9e-05	0.00469	CrCbGaD
Alimemazine—HRH1—Signaling by GPCR—PDE4D—prostate cancer	2.8e-05	0.000831	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.76e-05	0.000818	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—GNG5—prostate cancer	2.67e-05	0.000791	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—COMT—prostate cancer	2.66e-05	0.000788	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.64e-05	0.000784	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.62e-05	0.000777	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.61e-05	0.000773	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PTHLH—prostate cancer	2.56e-05	0.000759	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—JUP—prostate cancer	2.5e-05	0.000743	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—WNT4—prostate cancer	2.5e-05	0.000743	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.43e-05	0.00072	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ANXA1—prostate cancer	2.41e-05	0.000713	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.4e-05	0.00071	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MC2R—prostate cancer	2.39e-05	0.000708	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—RALBP1—prostate cancer	2.39e-05	0.000708	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PTHLH—prostate cancer	2.32e-05	0.000689	CbGpPWpGaD
Alimemazine—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.3e-05	0.000683	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PRKACB—prostate cancer	2.27e-05	0.000674	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HAO1—prostate cancer	2.27e-05	0.000674	CbGpPWpGaD
Alimemazine—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.27e-05	0.000673	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—CALCA—prostate cancer	2.25e-05	0.000668	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PPP3CA—prostate cancer	2.22e-05	0.000657	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—CXCL12—prostate cancer	2.2e-05	0.000652	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ANXA1—prostate cancer	2.18e-05	0.000648	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PENK—prostate cancer	2.13e-05	0.000631	CbGpPWpGaD
Alimemazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	2.12e-05	0.000628	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	2.09e-05	0.00062	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CALCA—prostate cancer	2.05e-05	0.000606	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GHR—prostate cancer	2.03e-05	0.000602	CbGpPWpGaD
Alimemazine—HRH1—G alpha (q) signalling events—PIK3CA—prostate cancer	2.03e-05	0.000602	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PRKCQ—prostate cancer	2.01e-05	0.000595	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CXCL12—prostate cancer	2e-05	0.000592	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	1.97e-05	0.000586	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NRP1—prostate cancer	1.95e-05	0.000578	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ADRB2—prostate cancer	1.89e-05	0.00056	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CBR1—prostate cancer	1.85e-05	0.000549	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ADI1—prostate cancer	1.85e-05	0.000549	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—TST—prostate cancer	1.85e-05	0.000549	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CSAD—prostate cancer	1.85e-05	0.000549	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PSAT1—prostate cancer	1.85e-05	0.000549	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GRHL1—prostate cancer	1.85e-05	0.000549	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—VAV3—prostate cancer	1.84e-05	0.000546	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PRKCQ—prostate cancer	1.82e-05	0.000541	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	1.81e-05	0.000538	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GNRH1—prostate cancer	1.81e-05	0.000537	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VIP—prostate cancer	1.81e-05	0.000537	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—ITPR1—prostate cancer	1.79e-05	0.000529	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—LPAR1—prostate cancer	1.75e-05	0.00052	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GRP—prostate cancer	1.75e-05	0.00052	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PLCB2—prostate cancer	1.74e-05	0.000515	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—LRP2—prostate cancer	1.74e-05	0.000515	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GRHPR—prostate cancer	1.72e-05	0.000511	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.72e-05	0.000511	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.72e-05	0.000511	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CKMT2—prostate cancer	1.72e-05	0.000511	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ADRB2—prostate cancer	1.71e-05	0.000508	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—P4HB—prostate cancer	1.7e-05	0.000505	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CX3CL1—prostate cancer	1.7e-05	0.000505	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—VAV3—prostate cancer	1.67e-05	0.000496	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HIST1H2BG—prostate cancer	1.67e-05	0.000496	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PDE4D—prostate cancer	1.66e-05	0.000491	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GRB7—prostate cancer	1.66e-05	0.000491	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—ITPR1—prostate cancer	1.62e-05	0.000481	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—RFK—prostate cancer	1.62e-05	0.00048	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AOX1—prostate cancer	1.62e-05	0.00048	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTM3—prostate cancer	1.62e-05	0.00048	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.62e-05	0.00048	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PGAM2—prostate cancer	1.62e-05	0.00048	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.62e-05	0.00048	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NAGLU—prostate cancer	1.62e-05	0.00048	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HIST1H4H—prostate cancer	1.61e-05	0.000479	CbGpPWpGaD
Alimemazine—HRH1—GPCR ligand binding—CXCL8—prostate cancer	1.61e-05	0.000478	CbGpPWpGaD
Alimemazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	1.61e-05	0.000476	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GNG5—prostate cancer	1.58e-05	0.000467	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AMACR—prostate cancer	1.54e-05	0.000455	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.54e-05	0.000455	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.54e-05	0.000455	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NAT1—prostate cancer	1.54e-05	0.000455	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—DEGS1—prostate cancer	1.54e-05	0.000455	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.46e-05	0.000434	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PTHLH—prostate cancer	1.37e-05	0.000407	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TGFBR1—prostate cancer	1.37e-05	0.000407	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AKR1C3—prostate cancer	1.35e-05	0.0004	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PRKACB—prostate cancer	1.34e-05	0.000398	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PPP3CA—prostate cancer	1.31e-05	0.000388	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—THBS1—prostate cancer	1.31e-05	0.000388	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.31e-05	0.000387	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HPGD—prostate cancer	1.31e-05	0.000387	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ANXA1—prostate cancer	1.29e-05	0.000383	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PRKCZ—prostate cancer	1.27e-05	0.000376	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	1.24e-05	0.000367	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.23e-05	0.000364	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGFR4—prostate cancer	1.22e-05	0.000363	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PARP1—prostate cancer	1.22e-05	0.000363	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CALCA—prostate cancer	1.21e-05	0.000358	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.19e-05	0.000354	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MTAP—prostate cancer	1.19e-05	0.000354	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CXCL12—prostate cancer	1.18e-05	0.00035	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.16e-05	0.000345	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.16e-05	0.000345	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	1.12e-05	0.000333	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CASP9—prostate cancer	1.11e-05	0.00033	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.11e-05	0.000329	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ACSL4—prostate cancer	1.11e-05	0.000329	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	1.09e-05	0.000323	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NGFR—prostate cancer	1.08e-05	0.000319	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PRKCQ—prostate cancer	1.08e-05	0.000319	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PHGDH—prostate cancer	1.06e-05	0.000316	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—UMPS—prostate cancer	1.06e-05	0.000316	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ARG2—prostate cancer	1.06e-05	0.000316	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MAP3K7—prostate cancer	1.06e-05	0.000316	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—LDHB—prostate cancer	1.04e-05	0.000309	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.02e-05	0.000304	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGF10—prostate cancer	1.02e-05	0.000303	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ADRB2—prostate cancer	1.01e-05	0.0003	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—JAK2—prostate cancer	9.99e-06	0.000296	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	9.95e-06	0.000295	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PDHA1—prostate cancer	9.89e-06	0.000293	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—TCN2—prostate cancer	9.89e-06	0.000293	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—UCP3—prostate cancer	9.89e-06	0.000293	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA3—prostate cancer	9.89e-06	0.000293	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	9.88e-06	0.000293	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VAV3—prostate cancer	9.87e-06	0.000293	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TGFBR2—prostate cancer	9.73e-06	0.000289	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ITPR1—prostate cancer	9.58e-06	0.000284	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	9.48e-06	0.000281	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HSD3B1—prostate cancer	9.44e-06	0.00028	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC22A3—prostate cancer	9.44e-06	0.00028	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IGF1R—prostate cancer	9.16e-06	0.000271	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	9.11e-06	0.00027	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—JAK2—prostate cancer	9.07e-06	0.000269	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—TBXAS1—prostate cancer	9.05e-06	0.000268	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA4—prostate cancer	9.05e-06	0.000268	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA2—prostate cancer	8.82e-06	0.000261	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—LPL—prostate cancer	8.78e-06	0.00026	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—IL2—prostate cancer	8.71e-06	0.000258	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ABCG5—prostate cancer	8.71e-06	0.000258	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.71e-06	0.000258	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PDGFRB—prostate cancer	8.7e-06	0.000258	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	8.61e-06	0.000255	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTA1—prostate cancer	8.51e-06	0.000252	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ITGB3—prostate cancer	8.48e-06	0.000251	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HSD3B2—prostate cancer	8.41e-06	0.000249	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTO1—prostate cancer	8.41e-06	0.000249	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NAT2—prostate cancer	8.41e-06	0.000249	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—CXCL8—prostate cancer	8.28e-06	0.000245	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ERBB3—prostate cancer	8.22e-06	0.000244	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGFR2—prostate cancer	8.21e-06	0.000243	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PLCB2—prostate cancer	8.06e-06	0.000239	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—LRP2—prostate cancer	8.06e-06	0.000239	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2C18—prostate cancer	8.06e-06	0.000239	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—IL2—prostate cancer	7.91e-06	0.000235	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—P4HB—prostate cancer	7.91e-06	0.000235	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TERT—prostate cancer	7.88e-06	0.000234	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.69e-06	0.000228	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—HIF1A—prostate cancer	7.54e-06	0.000224	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SULT2A1—prostate cancer	7.5e-06	0.000222	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MED12—prostate cancer	7.38e-06	0.000219	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—LEP—prostate cancer	7.36e-06	0.000218	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GNG5—prostate cancer	7.32e-06	0.000217	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CAV1—prostate cancer	7.29e-06	0.000216	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—KDR—prostate cancer	7.21e-06	0.000214	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NCOA3—prostate cancer	7.05e-06	0.000209	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ESR1—prostate cancer	7.02e-06	0.000208	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—BAD—prostate cancer	6.86e-06	0.000203	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—HPGDS—prostate cancer	6.72e-06	0.000199	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.68e-06	0.000198	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—APC—prostate cancer	6.64e-06	0.000197	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	6.64e-06	0.000197	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IRS1—prostate cancer	6.56e-06	0.000195	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EGF—prostate cancer	6.56e-06	0.000195	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTT1—prostate cancer	6.52e-06	0.000193	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ACHE—prostate cancer	6.52e-06	0.000193	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.45e-06	0.000191	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—GSK3B—prostate cancer	6.37e-06	0.000189	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—INS—prostate cancer	6.29e-06	0.000186	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.27e-06	0.000186	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PRKACB—prostate cancer	6.24e-06	0.000185	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.17e-06	0.000183	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CREBBP—prostate cancer	6.16e-06	0.000183	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IGF1—prostate cancer	6.08e-06	0.00018	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—EGFR—prostate cancer	6.05e-06	0.000179	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NCOA2—prostate cancer	5.88e-06	0.000174	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	5.88e-06	0.000174	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	5.84e-06	0.000173	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	5.78e-06	0.000171	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	5.77e-06	0.000171	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—KRAS—prostate cancer	5.72e-06	0.000169	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.61e-06	0.000166	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—FGF2—prostate cancer	5.59e-06	0.000166	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—NOS3—prostate cancer	5.51e-06	0.000163	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.48e-06	0.000163	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NQO1—prostate cancer	5.42e-06	0.000161	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—JAK2—prostate cancer	5.36e-06	0.000159	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—TH—prostate cancer	5.34e-06	0.000158	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	5.25e-06	0.000156	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MDM2—prostate cancer	5.23e-06	0.000155	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.2e-06	0.000154	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—ERBB2—prostate cancer	5.16e-06	0.000153	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	5.09e-06	0.000151	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GGT1—prostate cancer	5.03e-06	0.000149	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NCOA1—prostate cancer	4.96e-06	0.000147	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CXCL8—prostate cancer	4.89e-06	0.000145	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.89e-06	0.000145	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	4.78e-06	0.000142	CbGpPWpGaD
Alimemazine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	4.72e-06	0.00014	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—RXRA—prostate cancer	4.72e-06	0.00014	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CASP3—prostate cancer	4.68e-06	0.000139	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IL2—prostate cancer	4.67e-06	0.000139	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—IL6—prostate cancer	4.65e-06	0.000138	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CCND1—prostate cancer	4.56e-06	0.000135	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—COMT—prostate cancer	4.54e-06	0.000135	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTP1—prostate cancer	4.52e-06	0.000134	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	4.51e-06	0.000134	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ITPR1—prostate cancer	4.45e-06	0.000132	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MMP9—prostate cancer	4.42e-06	0.000131	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	4.41e-06	0.000131	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PTEN—prostate cancer	4.4e-06	0.00013	CbGpPWpGaD
Alimemazine—HRH1—Signaling by GPCR—AKT1—prostate cancer	4.29e-06	0.000127	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—TYMS—prostate cancer	4.2e-06	0.000125	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EP300—prostate cancer	4.19e-06	0.000124	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—GSTM1—prostate cancer	4.15e-06	0.000123	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—LPL—prostate cancer	4.08e-06	0.000121	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—SRC—prostate cancer	4.08e-06	0.000121	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—VEGFA—prostate cancer	3.97e-06	0.000118	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.94e-06	0.000117	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—STAT3—prostate cancer	3.93e-06	0.000117	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—ERCC2—prostate cancer	3.91e-06	0.000116	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—MTHFR—prostate cancer	3.67e-06	0.000109	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—MYC—prostate cancer	3.65e-06	0.000108	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TGFB1—prostate cancer	3.64e-06	0.000108	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PPARA—prostate cancer	3.6e-06	0.000107	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—EGFR—prostate cancer	3.57e-06	0.000106	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CAV1—prostate cancer	3.39e-06	0.0001	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—KRAS—prostate cancer	3.38e-06	0.0001	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	3.1e-06	9.2e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.08e-06	9.15e-05	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—TP53—prostate cancer	3e-06	8.9e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—INS—prostate cancer	2.92e-06	8.66e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—CREBBP—prostate cancer	2.86e-06	8.48e-05	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—IL6—prostate cancer	2.75e-06	8.14e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.71e-06	8.04e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—NOS3—prostate cancer	2.56e-06	7.59e-05	CbGpPWpGaD
Alimemazine—HRH1—Signaling Pathways—AKT1—prostate cancer	2.53e-06	7.51e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.36e-06	7.01e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PTGS2—prostate cancer	2.34e-06	6.94e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PTEN—prostate cancer	2.04e-06	6.06e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—EP300—prostate cancer	1.95e-06	5.78e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.44e-06	4.27e-05	CbGpPWpGaD
Alimemazine—CYP3A4—Metabolism—AKT1—prostate cancer	1.18e-06	3.49e-05	CbGpPWpGaD
